- Release Date: 02/12/20 09:08
- Summary: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
- Price Sensitive: Yes
- Download Document 116.21KB
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
MSB
mesoblast limited
Add to My Watchlist
1.24%
!
$1.64

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
-
- There are more pages in this discussion • 513 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.64 |
Change
0.020(1.24%) |
Mkt cap ! $2.089B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $4.614M | 2.816M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 51575 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 29227 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 19941 | 1.635 |
18 | 94019 | 1.630 |
17 | 253719 | 1.625 |
18 | 250020 | 1.620 |
10 | 157705 | 1.615 |
Price($) | Vol. | No. |
---|---|---|
1.640 | 19712 | 28 |
1.645 | 106063 | 24 |
1.650 | 161325 | 23 |
1.655 | 111070 | 11 |
1.660 | 141358 | 9 |
Last trade - 13.46pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online